Q: What must be documented at the bedside and in the transfusion record?

Product name, total grams, time, indication , infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Q: What must be documented at the bedside and in the transfusion record?

Product name, total grams, time, indication , infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Q: What must be documented at the bedside and in the transfusion record?

Product name, total grams, time, indication , infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Q: What must be documented at the bedside and in the transfusion record?

Product name, total grams, time, indication , infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 1

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 2

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 3

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 4

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 5

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 6

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 7

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 8

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 9

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 10

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 11

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 12

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 13

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 14

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 15

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 16

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 17

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 18

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 19

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 20

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 21

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 22

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 23

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 24

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 25

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 26

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 27

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Question 28

What must be documented at the bedside and in the transfusion record?

admin_fibryga_2025 · Accepted Answer

Product name, total grams, time, indication, infusion rate, pre and post fibrinogen or viscoelastic values, all lot numbers, adverse events, and prescriber identity.

Question 29

How do I report suspected adverse reactions or product quality issues?

admin_fibryga_2025 · Accepted Answer

Report through institutional pharmacovigilance and to the manufacturer’s medical information line with complete lot and clinical details.

Question 30

What should Blood Bank record in addition to standard fields?

admin_fibryga_2025 · Accepted Answer

Issue time, receipt confirmation, storage conditions if any delay, complete lot traceability, and the indication provided.

Frequently Asked Questions

Home / FAQs

For Canadian healthcare professionals only.

Documentation, traceability, and pharmacovigilance

What must be documented at the bedside and in the transfusion record?

How do I report suspected adverse reactions or product quality issues?

What should Blood Bank record in addition to standard fields?